These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 3787480
1. [4-component chemotherapy and radiation therapy of breast cancer]. Gritsaĭ AA, Lichinitser MR, Vyshinskaia GV, Kondrat'eva AP, Aplevich NN. Ter Arkh; 1986; 58(9):105-8. PubMed ID: 3787480 [Abstract] [Full Text] [Related]
2. [Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer]. Voznyĭ EK, Besova NS, Kurkina TV, Al'tshtuller IuB. Antibiotiki; 1984 Jun; 29(6):463-8. PubMed ID: 6476811 [Abstract] [Full Text] [Related]
3. [Use of adriamycin in the treatment of metastatic breast cancer]. Dymarskiĭ LIu, Sanchakova AV, Aleksandrova GI, Trishkina EA. Vopr Onkol; 1984 Jun; 30(6):67-73. PubMed ID: 6547554 [Abstract] [Full Text] [Related]
8. [Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones]. Lichinitser MR, Vyshinskaia GV, Gritsaĭ AA, Kondrat'eva AP, Luk'ianchenko AB. Med Radiol (Mosk); 1986 Feb; 31(2):28-31. PubMed ID: 3951344 [Abstract] [Full Text] [Related]
12. [Simultaneous combined radio-/chemotherapy of locally recurring breast cancer]. Renner H, Lang C, Ziegler K. Strahlentherapie; 1984 Jul; 160(7):421-4. PubMed ID: 6464045 [Abstract] [Full Text] [Related]
13. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma. Ribas A, Albanell J, Solé-Calvo LA, Gallardo E, Bellmunt J, Vera R, Vidal R, Carulla J, Baselga J. Cancer; 1998 Mar 01; 82(5):878-85. PubMed ID: 9486577 [Abstract] [Full Text] [Related]
14. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III]. Bustová I. Klin Onkol; 2009 Mar 01; 22(1):17-21. PubMed ID: 19534435 [Abstract] [Full Text] [Related]
19. [Comparative evaluation of 2 schedules of administration of anti- neoplastic drugs by the CMF protocol in disseminated breast cancer]. Korman DB, Snimshchikov VA, Dobroskok LB, Maslova IA, Mikaélian SG, Pines EV. Sov Med; 1991 Mar 01; (3):14-5. PubMed ID: 1882280 [Abstract] [Full Text] [Related]
20. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial. Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA. Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712 [Abstract] [Full Text] [Related] Page: [Next] [New Search]